Stronghold Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$229K Buy
9,509
+88
+0.9% +$2.3K 0.31% 110
2026
Q1
$265K Buy
9,421
+132
+1% +$3.51K 0.4% 84
2025
Q4
$231K Buy
+9,289
New +$234K 0.34% 95

Other funds holding PFE

Stronghold Wealth Management's PFE Position: Q2 2026 in Review

Stronghold Wealth Management increased its Pfizer (PFE) stake by 0.93% in Q2 2026, buying an estimated $2.3K and bringing the position to 9,509 shares worth $229K. The position accounts for 0.31% of the portfolio, ranked #110.

Stronghold Wealth Management first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $265K in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Stronghold Wealth Management held 9,509 shares of Pfizer worth $229K as of Q2 2026.
  • Stronghold Wealth Management bought 88 Pfizer shares in Q2 2026, an estimated $2.3K.
  • Pfizer made up 0.31% of Stronghold Wealth Management's portfolio in Q2 2026, its #110 holding.
  • Stronghold Wealth Management first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Stronghold Wealth Management's Pfizer position peaked at $265K in Q1 2026.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Stronghold Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.